White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population

Hypertension Research

Volumn 31, Issue 7, 2008, Pages 1391-1397

  Tatsukawa, Yoshimi ^a   Hsu, Wan Ling ^a   Yamada, Michiko ^a   Cologne, John B ^a   Suzuki, Gen ^b   Yamamoto, Hideya ^c   Yamane, Kiminori ^c   Akahoshi, Masazumi ^a   Fujiwara, Saeko ^a   Kohno, Nobuoki ^c  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Epidemiology; Follow up study; Hypertension; Leukocyte; Neutrophil

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; JAPANESE; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEUTROPHIL COUNT; PREDICTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 55449107391     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1391     Document Type: Article

References (45)

1. Margolis KL, Manson JE, Greenland P, et al: Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165: 500-508.
2. Zalokar J, Richard JL, Claude JR: Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981; 304: 465-468.
3. Brown DW, Ford ES, Giles WH, Croft JB, Balluz LS, Mokdad AH: Associations between white blood cell count and risk for cerebrovascular disease mortality: NHANES II Mortality Study, 1976-1992. Ann Epidemiol 2004; 14: 425-430.
4. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA: White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis Risk in Communities Study. Am J Epidemiol 2001; 154: 758-764.
5. Sweetnam PM, Thomas HF, Yarnell JWG, Baker IA, Elwood PC: Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell Studies. Am J Epidemiol 1997; 145: 416-421.
6. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
7. Danesh J, Wheeler JG, Hirschfield GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-1397.
8. Cushman M, Arnold AM, Psaty BM, et al: C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005; 112: 25-31.
9. Shankar A, Klein BE, Klein R: Relationship between white blood cell count and incident hypertension. Am J Hypertens 2004; 17: 233-239.
10. Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K: White blood cell count as a risk factor for hypertension; a study of Japanese male office workers. J Hypertens 2002; 20: 851-857.
11. Gillum RF, Mussolino ME: White blood cell count and hypertension incidence: The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1994; 47: 911-919.
12. Friedman GD, Selby JV, Quesenberry CP Jr: The leukocyte count: a predictor of hypertension. J Clin Epidemiol 1990; 43: 907-911.
13. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951.
14. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM: Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002; 22: 1668-1673.
15. Smedly LA, Tonnesen MG, Sandhause RA, et al: Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77: 1233-1243.
16. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
17. Lassègue B, Clempus RE: Vascular NAD(P)H oxidase: specific features, expression and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
18. Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J: Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005; 28: 107-112.
19. Taniyama Y, Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42: 1075-1081.
20. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury. Part II: Animal and human studies. Circulation 2003; 108: 2034-2040.
21. Sela S, Mazor R, Amsalam M, Yagil C, Yagil Y, Kristal B: Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra Rat. Hypertension 2004; 44: 764-769.
22. Schmid-Schönbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW: Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 1991; 17: 323-330.
23. Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K: Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation 1996; 94: 61-66.
24. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G: Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 2004; 16: 622-632.
25. WHO Study Group: Diabetes Mellitus. Geneva, World Health Organization, Technical Report Series no 727, 1985.
26. Kannel WB, Sorlie P: Some health benefits of physical activity: the Framingham Study. Arch Intern Med 1979; 139: 857-861.
27. Wheeler JG, Mussolino ME, Gillum RF, Danesh J: Associations between differential leukocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30 374 individuals. Eur Heart J 2004; 25: 1287-1292.
28. Ueshima H: Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-286.
29. Sunyer J, Muñoz A, Peng Y, et al: Longitudinal relation between smoking and white blood cells. Am J Epidemiol 1996; 144: 734-741.
30. Yoshiike N, Seino F, Tajima S, et al: Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev b2002; 3: 183-190.
31. Nagasawa N, Tamakoshi K, Yatsuya H, et al: Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 2004; 68: 892-897.
32. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
33. Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
34. Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
35. Straczkowski M, Dzienis-Straczkowska S, Stêpieñ A, Kowalska I, Szelachowska M, Kinalska I: Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J Clin Endocrinol Metab 2002; 87: 4602-4606.
36. Herder C, Haastert B, Müller-Scholze S, et al: Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 2005; 54 (Suppl 2): S11-S17.
37. Boekholdt SM, Peters RJ, Hack CE, et al: IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004; 24: 1503-1508.
38. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9: 617-648.
39. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
40. Mügge A, Lopez JA: Do leukocytes have a role in hypertension? Hypertension 1991; 17: 331-333.
41. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
42. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
43. Nakamura K, Okamura T, Hayakawa T, et al: The proportion of individuals with alcohol-induced hypertension among total hypertensives in a general Japanese population: NIPPON DATA90. Hypertens Res 2007; 30: 663-668.
44. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H: Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension. Hypertens Res 2007; 30: 879-886.
45. Japanese Society of Hypertension: Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29 (Suppl): S1-S105.